YU33103A - Formulacija rastvora za inhalaciju sa soli tiotropijuma - Google Patents

Formulacija rastvora za inhalaciju sa soli tiotropijuma

Info

Publication number
YU33103A
YU33103A YU33103A YUP33103A YU33103A YU 33103 A YU33103 A YU 33103A YU 33103 A YU33103 A YU 33103A YU P33103 A YUP33103 A YU P33103A YU 33103 A YU33103 A YU 33103A
Authority
YU
Yugoslavia
Prior art keywords
formulation containing
solution formulation
tiotropium salt
inhalative solution
inhalative
Prior art date
Application number
YU33103A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Original Assignee
Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU33103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh. & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority to MEP-2008-407A priority Critical patent/ME00242B/me
Publication of YU33103A publication Critical patent/YU33103A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU33103A 2000-10-31 2001-10-24 Formulacija rastvora za inhalaciju sa soli tiotropijuma YU33103A (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-2008-407A ME00242B (me) 2000-10-31 2001-10-24 Formulacija rastvora za inhalaciju sa soli tiotropijuma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31

Publications (1)

Publication Number Publication Date
YU33103A true YU33103A (sh) 2006-05-25

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
YU33103A YU33103A (sh) 2000-10-31 2001-10-24 Formulacija rastvora za inhalaciju sa soli tiotropijuma

Country Status (33)

Country Link
EP (1) EP1335729A2 (hr)
JP (1) JP4559703B2 (hr)
KR (1) KR100983208B1 (hr)
CN (1) CN1237970C (hr)
AR (1) AR038765A1 (hr)
AU (2) AU2174102A (hr)
BG (1) BG66425B1 (hr)
BR (1) BR0115016A (hr)
CA (1) CA2427583C (hr)
CZ (1) CZ305033B6 (hr)
DE (1) DE10152369A1 (hr)
EA (1) EA009068B1 (hr)
EC (1) ECSP034570A (hr)
EE (1) EE05343B1 (hr)
HK (1) HK1060569A1 (hr)
HR (1) HRP20030337A2 (hr)
HU (1) HUP0301377A3 (hr)
IL (2) IL155676A0 (hr)
ME (1) ME00242B (hr)
MX (1) MXPA03003750A (hr)
MY (1) MY132777A (hr)
NO (1) NO332524B1 (hr)
NZ (1) NZ526024A (hr)
PE (1) PE20020518A1 (hr)
PL (1) PL361001A1 (hr)
SA (1) SA01220503B1 (hr)
SK (1) SK288031B6 (hr)
TW (1) TWI296934B (hr)
UA (1) UA76435C2 (hr)
UY (1) UY26991A1 (hr)
WO (1) WO2002036591A2 (hr)
YU (1) YU33103A (hr)
ZA (1) ZA200303045B (hr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02010565A (es) 2000-04-28 2004-05-17 Kosan Biosciences Inc Produccion de policetidos.
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2004279438A1 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Methods for treating diseases and conditions with inverse agonists
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
MX2007011273A (es) * 2005-03-16 2007-11-08 Meda Pharma Gmbh & Co Kg La combinacion de anticolinergicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias.
EP2034990A4 (en) * 2006-05-26 2013-03-06 Dey L P DIRTIBLE COMPOSITIONS OF QUATERNARY AMMONIUM MUSCARIN RECEPTOR ANTAGONISTS
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
TR200907237A2 (tr) * 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Tiotropyum kuru toz kombinasyonu
CN111936124A (zh) * 2018-07-26 2020-11-13 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
CN111971034A (zh) * 2018-07-26 2020-11-20 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
DK0835098T3 (da) * 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stabilt lægemiddelpræparat til frembringlese af drivgasfrie aerosoler
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
CA2256721A1 (en) * 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
ATE234604T1 (de) * 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
HK1060569A1 (en) 2004-08-13
PE20020518A1 (es) 2002-07-12
EA009068B1 (ru) 2007-10-26
PL361001A1 (en) 2004-09-20
HUP0301377A3 (en) 2005-12-28
EP1335729A2 (de) 2003-08-20
NO332524B1 (no) 2012-10-08
SK5262003A3 (en) 2003-10-07
ZA200303045B (en) 2004-04-22
HUP0301377A2 (hu) 2003-10-28
SK288031B6 (sk) 2012-12-03
KR100983208B1 (ko) 2010-09-20
EA200300483A1 (ru) 2003-12-25
MXPA03003750A (es) 2004-10-15
IL155676A0 (en) 2003-11-23
ECSP034570A (es) 2003-06-25
DE10152369A1 (de) 2002-05-08
JP2004523482A (ja) 2004-08-05
CA2427583A1 (en) 2002-05-10
JP4559703B2 (ja) 2010-10-13
CZ305033B6 (cs) 2015-04-08
IL155676A (en) 2012-05-31
BR0115016A (pt) 2005-05-03
UA76435C2 (en) 2006-08-15
BG107726A (bg) 2004-11-30
ME00242B (me) 2011-05-10
CZ20031487A3 (cs) 2003-09-17
CN1237970C (zh) 2006-01-25
NZ526024A (en) 2005-10-28
SA01220503B1 (ar) 2007-03-10
CA2427583C (en) 2008-02-12
NO20031914D0 (no) 2003-04-29
EE05343B1 (et) 2010-10-15
EE200300202A (et) 2003-10-15
BG66425B1 (bg) 2014-04-30
UY26991A1 (es) 2002-06-20
AU2002221741B2 (en) 2007-04-05
CN1473044A (zh) 2004-02-04
AR038765A1 (es) 2005-01-26
KR20040010552A (ko) 2004-01-31
NO20031914L (no) 2003-06-23
WO2002036591A2 (de) 2002-05-10
AU2174102A (en) 2002-05-15
TWI296934B (en) 2008-05-21
HRP20030337A2 (en) 2005-04-30
WO2002036591A3 (de) 2002-07-25
MY132777A (en) 2007-10-31
MEP40708A (hr) 2011-02-10

Similar Documents

Publication Publication Date Title
YU33103A (sh) Formulacija rastvora za inhalaciju sa soli tiotropijuma
AP1572A (en) Crystalline monohydrate, method for producing the same and use thereof in the production of a medicament.
WO2007064658A3 (en) Safe and effective methods of administering therapeutic agents
RS76604A (en) Pressuriesed metered dose inhalers containing solutions of beta-2 agonists
MXPA03010162A (es) Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias.
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
TW200630364A (en) 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2007060104A3 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
IL195818A0 (en) Derivatives of 2-benzoyl-imidazopyridines, preparation ,method thereof and use of same in therapeutics
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
ECSP067111A (es) Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica
YU33003A (sh) Formulacija rastvora za inhalaciju sa soli tiotropijuma
MY137249A (en) Aerosol formulation for inhalation containing a tiotropium salt
RU2014114512A (ru) Водные композиции, содержащие арбекацин
SE0102440D0 (sv) New compound
JP2003502361A5 (hr)
TW200744606A (en) Use of tiotropium salts in the treatment of severe persistent asthma
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation